phagos

• phagos deploys a solution to fight the antibiotic resistance pandemic - starting in its biggest contributor, animal farming.
• We built an ML-driven bio platform unlocking unprecedented bacteriophage efficiency and are 10x faster than competitors to deliver. Clinical trials show up to +70% health improvements when using our solutions.
• Two billion-$ multinationals have already chosen phagos to replace their antibiotics. Our deal pipeline has a €65m ARR potential, including a signed contract with a €7.5m ARR potential. Commercialisation starts by year end.
  We’re raising €15m to deploy our current deal pipeline and further expand it to a €250m ARR potential.
• €10m+ are already committed by existing investors Hoxton and Demeter + followers.
   

You'll find our teaser on this link.

password: wordofmouth

I'd be happy to tell you more over a call! Please don't hesitate to book me on this link.